Multilingual database is in early beta - please report any issues you may have noticed.
Datos obtenidos:
2023.
Página actualizada:
2025-06-04
En la India, la terapia de reemplazo de nicotina (TRN) está permitida y es legal usar, vender y comprar productos de TRN en tiendas generales. Estos productos se regulan como medicamentos. El gobierno cubre íntegramente el costo de la TRN, ya que está incluida en la lista nacional de medicamentos esenciales. El tamaño del mercado de la TRN en la India fue de 33,09 millones de dólares estadounidenses en 2023.
Promoción de productos
| Year | Value | Reference/Comment |
|---|---|---|
| 2019 | 19.5 million € | 1A |
| 2023 | 33,09 millones de USD en 2023 | 1B |
Referencias:
- Consumer Health: Euromonitor from trade sources/national statistics. Date Exported: 8/9/2019. (c) Euromonitor International 2019
- Grand View Research. India Nicotine Replacement Therapy Market. Available at: https://www.grandviewresearch.com/industry-analysis/india-nicotine-replacement-therapy-market-report. Accessed: 9 May 2025.
0.3 €
2
2019
Referencias:
- Grand View Research. India Nicotine Replacement Therapy Market. Available at: https://www.grandviewresearch.com/industry-analysis/india-nicotine-replacement-therapy-market-report. Accessed: 9 May 2025.
- Consumer Health: Euromonitor from trade sources/national statistics. Date Exported: 8/9/2019. (c) Euromonitor International 2019
Regulación
Referencias:
- WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-ind.pdf?sfvrsn=4d7d5aa2_3&download=true. Accessed: 6 May 2025.
Disponibilidad
Sí
1
2022
Sí
1
2022
| Year | Value | Reference/Comment |
|---|---|---|
| 2019 | Sí | 1A |
| 2022 | Sí | 1B |
Referencias:
- WHO Report on the Global Tobacco Epidemic 2019. https://www.who.int/tobacco/global_report/en/ (2019).
- WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-ind.pdf?sfvrsn=4d7d5aa2_3&download=true. Accessed: 6 May 2025.
Sí
2
2019
| Year | Value | Reference/Comment |
|---|---|---|
| 2019 | muchas tiendas generales sin receta | 1A |
| 2022 | Tiendas generales | 1B |
Referencias:
- WHO Report on the Global Tobacco Epidemic 2019. https://www.who.int/tobacco/global_report/en/ (2019).
- WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-ind.pdf?sfvrsn=4d7d5aa2_3&download=true. Accessed: 6 May 2025.
Referencias:
- WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-ind.pdf?sfvrsn=4d7d5aa2_3&download=true. Accessed: 6 May 2025.
- WHO Report on the Global Tobacco Epidemic 2019. https://www.who.int/tobacco/global_report/en/ (2019).
Apoyo formal
Sí NRT is on the country's essential drugs list.
1
A
2022
Referencias:
- WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-ind.pdf?sfvrsn=4d7d5aa2_3&download=true. Accessed: 6 May 2025.
Comentarios:
- NRT cost is fully covered by the government.
The GSTHR database is updated regularly by our team.
However, please be aware that the information we provide does not constitute legal advice.
We cannot guarantee that the information is up to date or accurate, as the regulatory status of different product
categories can change at short notice and with little publicity.
If you wish to check the legal status of use or possession of any safer nicotine product in a specific country or region,
you should verify the information independently.
If you have reason to think that the information supplied on the GSTHR is inaccurate, please contact us with details
and any references and we will rectify any errors.